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background: Transapical (TA-TAVR) vs. Transfemoral (TF-TAVR) approach for TAVR is largely dictated by adequacy of aortoiliac and femoral arteries 
to support large catheter access. There is limited data on direct comparison of clinical outcomes between the two approaches.
Method: 92 consecutive TAVR procedures using balloon-expandable Edwards SAPIEN valve performed in a single center between 01/2012 and 
08/2013 were analyzed. Study endpoints were defined according to the revised VARC-2 criteria. Propensity score-adjusted analysis (adjusted for 20 
variables) of adverse clinical outcomes at 30 days was performed.
results: TA-TAVR was performed in 23 (25%) and TF-TAVR in 69 patients (75%). TA-TAVR was associated with increased risk for significant acute 
kidney injury (stage 2 or 3 defined by VARC-2 AKIN criteria) and conduction disturbance requiring permanent pacemaker. Thirty-day mortality, major 
bleeding, vascular complications, stroke/TIA, perivalvular aortic regurgitation, length of hospital stay, hours spent in ICU, and composite endpoint 
of death, major bleeding, vascular complication, stroke/TIA, myocardial infarction were not significantly different between the two approaches (see 
table).
conclusion: In our observational registry, after propensity score adjustment, we found that TA-TAVR was a safe alternative for selected patients but 
was associated with significantly higher risk for significant AKI and conduction disturbance requiring pacemaker compared with TF-TAVR.
 
